Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Recipient : Thermo Fisher Scientific
Deal Size : Undisclosed
Deal Type : Partnership
Mirai Bio Partners with Thermo Fisher to Accelerate Genetic Medicines Development
Details : Through the collaboration, Thermo Fisher will be paired with Mirai's innovative technology platform for optimizing the design, delivery and development of novel nucleic acid therapeutics.
Product Name : Undisclosed
Product Type : Oligonucleotide
Upfront Cash : Undisclosed
May 20, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Recipient : Thermo Fisher Scientific
Deal Size : Undisclosed
Deal Type : Partnership